{"id":47,"date":"2021-05-10T05:10:55","date_gmt":"2021-05-10T05:10:55","guid":{"rendered":"http:\/\/www.techex.in\/matchmaker\/03\/?page_id=47"},"modified":"2021-08-23T09:03:11","modified_gmt":"2021-08-23T09:03:11","slug":"showcase-schedule","status":"publish","type":"page","link":"https:\/\/www.techex.in\/matchmaker\/03\/showcase-schedule\/","title":{"rendered":"Showcase schedule"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

Technology showcase on biosimilars: 31 Aug 2021<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Detailed showcase outline<\/a>\u00a0| Register here<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

Showcase time schedule<\/strong><\/p><\/td><\/tr>

Time<\/strong><\/p><\/td>

Duration<\/strong><\/p><\/td>

Session title<\/strong><\/p><\/td>

Speaker <\/strong><\/p><\/td><\/tr>

4:00- 4:05 PM<\/p><\/td>

5 mins<\/p><\/td>

Introduction to Venture Center and TechEx.in<\/p><\/td>

TechEx team<\/p><\/td><\/tr>

4:05- 4:10 PM<\/p><\/td>

5 mins<\/p><\/td>

Set the stage for the showcase<\/p><\/td>

  • Premnath V, Director Venture Center<\/li>
  • Pradnya Aradhye<\/li><\/ul><\/td><\/tr>

4:10- 4:40 PM<\/p><\/td>

30 mins<\/p><\/td>

  • Offering 1:\u00a0 Trastuzumab<\/li>
  • Offering 2:\u00a0 Ranibizumab<\/li>
  • Other capabilities and molecules in development<\/li><\/ul><\/td>

Dr Anurag Rathore, IIT Delhi<\/p><\/td><\/tr>

4:40- 4:50 PM<\/p><\/td>

10 mins<\/p><\/td>

Q & A<\/p><\/td>

\u00a0<\/td><\/tr>

4:50- 5:20 PM<\/p><\/td>

30 mins<\/p><\/td>

  • Offering 1:\u00a0 Insulin Detemir<\/li>
  • Offering 2:\u00a0 Certolizumab PEGOL<\/li>
  • \u00a0Other capabilities and molecules in development<\/li><\/ul><\/td>

Dr Natasa Skoko, ICGEB, Italy<\/p><\/td><\/tr>

5:20 – 5:30 PM<\/p><\/td>

10 mins<\/p><\/td>

Q & A<\/p><\/td>

\u00a0<\/td><\/tr>

5:30- 5:45 PM<\/p><\/td>

15 mins<\/p><\/td>

  • Offering 1: Adalimumab<\/li>
  • Other capabilities and molecules in development<\/li><\/ul><\/td>

Dr Sen, IMTECH, Chandigarh<\/p><\/td><\/tr>

5:45- 5:50 PM<\/p><\/td>

5 mins<\/p><\/td>

Q & A<\/p><\/td>

\u00a0<\/td><\/tr>

5:50- 6:20 PM<\/p><\/td>

30 mins<\/p><\/td>

  • Offering 1: Ranibizumab<\/li>
  • Offering 2: Anakinra<\/li>
  • Other capabilities and molecules in development<\/li><\/ul><\/td>

Dr Rahul Bhambure, CSIR-NCL, Pune<\/p><\/td><\/tr>

6:20- 6:30 PM<\/p><\/td>

10 mins<\/p><\/td>

Q & A<\/p><\/td>

\u00a0<\/td><\/tr>

6:30- 7:00 PM<\/p><\/td>

30 mins<\/p><\/td>

Concluding session – Comments from experts,<\/p>

Instructions for next steps, Vote of thanks<\/p><\/td>